| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/24/1994 | US5314678 Sodium iodide 131 I capsules |
| 05/24/1994 | US5314642 Hydrolysis |
| 05/24/1994 | US5314537 Gelatin coated caplets and process for making same |
| 05/24/1994 | US5314506 Crystallization method to improve crystal structure and size |
| 05/24/1994 | US5314471 Tissue inplant systems and methods for sustaining viable high cell densities within a host |
| 05/24/1994 | CA2019618C Zinc compound delivery system with improved taste and texture |
| 05/24/1994 | CA1329854C Biodegradable polymeric materials based on polyether glycols, processes for the preparation thereof and surgical articles made therefrom |
| 05/24/1994 | CA1329776C Anti-allergic extract |
| 05/24/1994 | CA1329775C Edible, baked compositions containing cholestyramine |
| 05/24/1994 | CA1329774C Methods for the treatment of osteoporosis and related disorders |
| 05/24/1994 | CA1329773C Pharmaceutical compositions useful for the treatment of uremia |
| 05/24/1994 | CA1329769C Liposomes with enhanced circulation time |
| 05/24/1994 | CA1329767C Controlled and delayed release oral pharmaceutical composition |
| 05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
| 05/24/1994 | CA1329761C Design of peptide hormones, chemotactic peptides and drug compounds |
| 05/19/1994 | DE4238779A1 Lyotropic mesophases for pharmaceutical, dermatological or cosmetic use - contains active ingredients from plants e.g. vitamins or proteins such as superoxidedismutase. |
| 05/18/1994 | EP0597636A1 Polyurethane pressure-sensitive adhesives |
| 05/18/1994 | EP0597414A2 Stable formulation of Senna extract |
| 05/18/1994 | EP0597071A1 Androgens for stimulating the central nervous system and for treating osteoporosis |
| 05/18/1994 | EP0597036A1 Microencapsulated quaternary ammonium compounds |
| 05/18/1994 | EP0597033A1 Igf-1 to improve the neural condition. |
| 05/18/1994 | EP0597029A1 W/o microemulsions. |
| 05/18/1994 | EP0597025A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
| 05/18/1994 | EP0597007A1 W/o microemulsions. |
| 05/18/1994 | EP0596984A1 Preparation of microparticles |
| 05/18/1994 | EP0596970A1 Prostaglandin-e 1? formulation |
| 05/18/1994 | EP0596962A1 Therapeutic compositions and methods |
| 05/18/1994 | EP0596953A1 Emulsifier concentrates |
| 05/18/1994 | EP0596935A1 Antiviral pharmaceutical compositions for vaginal administration. |
| 05/18/1994 | EP0596908A1 Mouth-hygiene agent containing hydrogen peroxide stabilized by colloidal silver. |
| 05/18/1994 | EP0537139B1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
| 05/18/1994 | CN1086740A Composition based on absorbable precipitate SiO2 |
| 05/18/1994 | CN1086730A Fine powder of fruit of Chinese wolfberry, oil made of fruit of Chinese wolfberry and their producing methods |
| 05/18/1994 | CN1086728A Red ginseng and tuber of dwarf lily turf powder injection and its preparing method |
| 05/18/1994 | CN1086725A Health fragrant bag |
| 05/18/1994 | CN1086724A Atomized pudendal cleaning liquid |
| 05/18/1994 | CN1086708A Memanting-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 05/18/1994 | CN1024557C Process for composition containing associated compound of hyaluronic acid |
| 05/18/1994 | CN1024497C Method for preparing stable medicine suspending liquid of ximeitidin |
| 05/18/1994 | CN1024496C Process for manufacture of vitamin preparation |
| 05/17/1994 | US5312819 Schizophrenia |
| 05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
| 05/17/1994 | US5312627 Transdermal therapeutic system for the administration of drugs having bronchodilating activity |
| 05/17/1994 | US5312626 Lozenge or chewable tablet |
| 05/17/1994 | US5312620 Polymeric immunological adjuvants |
| 05/17/1994 | US5312615 Encapsulation, extrusion and filtration of liposomes |
| 05/17/1994 | US5312390 Fluid imbibation; reversibly sliding, telescoped housings |
| 05/17/1994 | US5312389 Osmotically driven syringe with programmable agent delivery |
| 05/17/1994 | US5312388 Osmotic device for delayed delivery of agent |
| 05/17/1994 | CA1329549C Microparticles containing an antimalarial active ingredient |
| 05/17/1994 | CA1329548C Liposomal preparation and antibiotic |
| 05/17/1994 | CA1329547C Skin permeation enhancer compositions using glycerol monooleate |
| 05/17/1994 | CA1329544C Galenic forms of allergens for sublingual administration |
| 05/17/1994 | CA1329543C Human growth hormone formulation |
| 05/17/1994 | CA1329542C Plasma and recombinant protein formulations in low ionic strength media |
| 05/11/1994 | WO1994010198A1 Method of reducing multidrug resistance in cells and tissues |
| 05/11/1994 | WO1994010140A1 High purity beta-carotene |
| 05/11/1994 | WO1994010129A1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 05/11/1994 | WO1994009898A1 Method of manufacturing microcapsules |
| 05/11/1994 | WO1994009848A1 Substance transfer system for topical application |
| 05/11/1994 | WO1994009829A1 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 05/11/1994 | WO1994009827A1 Process for making lipid conjugates |
| 05/11/1994 | WO1994009826A2 Drug delivery systems, characterised by a photolabile linkage |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009819A1 Microcrystalline cellulose as an immune adjuvant |
| 05/11/1994 | WO1994009816A1 Use of an enteric coated papain-containing food supplement for controlling auto immune diseases |
| 05/11/1994 | WO1994009799A1 Anti-inflammatory factor, method of isolation, and use |
| 05/11/1994 | WO1994009795A1 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 05/11/1994 | WO1994009794A1 Ophthalmic solution and method of use |
| 05/11/1994 | WO1994009785A2 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | WO1994009777A1 Transdermal delivery of ketorolac |
| 05/11/1994 | WO1994009762A1 Drug delivery device |
| 05/11/1994 | WO1994009761A1 Stable extended release oral dosage composition |
| 05/11/1994 | WO1994009758A1 Confectionery delivery system for pharmaceutically active substances |
| 05/11/1994 | WO1994009754A1 Preparations containing a fluorocarbon emulsion and usable as cosmetics or dermatics |
| 05/11/1994 | WO1994009746A1 Controlled release device |
| 05/11/1994 | WO1994009745A1 Capsule construction |
| 05/11/1994 | WO1994009744A1 Capsule cap |
| 05/11/1994 | WO1994009743A1 Vented capsule |
| 05/11/1994 | WO1994009735A1 Plaster with a supply of a medically active substance |
| 05/11/1994 | WO1994009625A2 Stabilization of fluorocarbon emulsions |
| 05/11/1994 | EP0596675A1 Artificial saliva compositions |
| 05/11/1994 | EP0596424A1 Process of 4-isopropylbenzylsalicilate as cutaneous anti-lipoperoxidant |
| 05/11/1994 | EP0596284A2 Antimycotic cosmetic and dermatological compositions containing fatty acid esters |
| 05/11/1994 | EP0596203A1 Preparations in solid particle form containing active and water-soluble polymers |
| 05/11/1994 | EP0596049A1 Defoaming composition |
| 05/11/1994 | EP0596032A1 Induction of cytotoxic t-lymphocyte responses |
| 05/11/1994 | EP0595854A1 Method of preparing a sterile-filterable solution of an active substance |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0508979B1 Occlusive body for administering a physiologically active substance |
| 05/11/1994 | CN1086429A Preparation method for medicine to cure spastic paralysis |
| 05/11/1994 | CN1086422A Novel compositions containing hyaluronic acid associates and a process for preparing same |
| 05/11/1994 | CN1086404A Solution concentration method by freezing |
| 05/11/1994 | CA2175479A1 Drug delivery systems |
| 05/11/1994 | CA2148458A1 Controlled release device |
| 05/11/1994 | CA2148457A1 Capsule construction |
| 05/11/1994 | CA2148456A1 Capsule cap |
| 05/11/1994 | CA2148108A1 Ophthalmic solution and method of use |
| 05/11/1994 | CA2147866A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | CA2147862A1 Drug delivery device |